The Nathanson Laboratory in Ahmanson Translational Imaging Division (ATID) in the Department of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA) is currently seeking a highly skilled and motivated postdoctoral researcher in signal transduction and metabolism in cancer. ATID is a highly collaborative and interdisciplinary environment for translational cancer research. Applicants should have extensive experience and knowledge in signal transduction and/or metabolism in cancer. A strong publication record and communication skills are also required.
The postdoctoral candidate will be involved in highly collaborative, translational research to develop new strategies to targeting Glioblastoma Multiforme (GBM), the most lethal brain tumor in adults. This will consist of interrogating the cross-talk between altered signal transduction and metabolic processes and examining mechanisms of resistance to targeted therapies in GBM.
- Ph.D in molecular biology, biochemistry, pharmacology, or related field with extensive knowledge and experience in signal transduction and/or metabolism in cancer
- Experience working with mice, including transplantation, drug administration (intraperitoneal, intravenous, and oral gavage)
- Strong molecular biology skill-set, including cell culture, PCR, RT-PCR, Western blot, immunoprecipitation, cloning
- LC-MS/MS experience preferred for quantitative metabolic/proteoimc measurements
- Effective communication skills, self-motivated, and strong work ethic
- Ability to work independently and in a group/collaborative environment
Interested applicants please send a cover letter, curriculum vitae (CV) and the names/contact information of three references to Dr. David Nathanson at firstname.lastname@example.org